Group 1 - The core viewpoint of the news is that Fabon Information has seen a significant increase in its stock price, rising 5.24% to 22.70 CNY per share, with a total market capitalization of 9.732 billion CNY and a trading volume of 339 million CNY [1] - Fabon Information has experienced a continuous stock price increase for four consecutive days, with a cumulative increase of 4.61% during this period [1] - The company, established on November 8, 2006, specializes in software technology outsourcing services, with its main business revenue composition being 75.31% from digital general technology services and 24.64% from digital innovation technology services [1] Group 2 - According to data, one fund under China Europe Fund holds a significant position in Fabon Information, with the China Europe Small Cap Growth Mixed A Fund (015880) holding 171,000 shares, accounting for 0.42% of the fund's net value [2] - The fund has generated a floating profit of approximately 193,200 CNY today, with a floating profit of 162,400 CNY during the four-day increase [2] - The China Europe Small Cap Growth Mixed A Fund was established on June 28, 2022, with a current scale of 306 million CNY and has achieved a year-to-date return of 0.96% [2] Group 3 - The fund managers of the China Europe Small Cap Growth Mixed A Fund are Qian Yating and Tang Minwei, with Qian having a tenure of 4 years and 66 days and a total fund asset scale of 5.022 billion CNY [3] - During Qian's tenure, the best fund return was 69.46%, while the worst was -14.61% [3] - Tang has a tenure of 168 days with a fund asset scale of 2.139 billion CNY, achieving a best return of 23.01% and a worst return of 2.61% during his tenure [3]

Group 1 - The core viewpoint of the news is that Shentong Technology has seen a significant increase in its stock price, rising 5.41% to 15.97 CNY per share, with a total market capitalization of 6.904 billion CNY as of January 6 [1] - Shentong Technology has experienced a continuous stock price increase for four consecutive days, with a cumulative increase of 3.41% during this period [1] - The company, established on March 4, 2005, specializes in the research, production, and sales of non-metal automotive components and molds, with 94.91% of its revenue coming from automotive parts sales [1] Group 2 - According to data from the top ten holdings of funds, one fund under China Europe Fund holds a significant position in Shentong Technology, with 268,500 shares, accounting for 0.41% of the fund's net value [2] - The fund, China Europe Small Cap Growth Mixed A, has generated a floating profit of approximately 220,200 CNY today, with a floating profit of 134,300 CNY during the four-day increase [2] - The fund was established on June 28, 2022, with a current scale of 306 million CNY, and has achieved a year-to-date return of 0.96% and a one-year return of 74.23% [2]

中欧盈欣稳健6个月持有期混合型基金中基金（FOF）基金合同全文和招募说明书全文于2026年1月6日 在本公司网站（www.zofund.com）和中国证监会基金电子披露网站（http://eid.csrc.gov.cn/fund）披露， 供投资者查阅。如有疑问可拨打本公司客服电话（021-68609700、400-700-9700）咨询。 本基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产，但不保证本基金一定盈利，也不 保证最低收益。请充分了解本基金的风险收益特征，审慎做出投资决定。 MACD金叉信号形成，这些股涨势不错！ 特此公告。 中欧基金管理有限公司 2026年1月6日 ...

Fund Overview - The fund is named "China Europe Yingxin Stable 6-Month Holding Period Mixed Fund of Funds (FOF)" and is managed by China Europe Fund Management Co., Ltd. [14][1] - The fund's A-class share code is 025218, and the C-class share code is 025219 [3][14]. Fund Structure - This fund operates as a contract-based open-end fund with a lock-up period of 6 months for each share, after which it enters an open holding period [14][15]. - During the lock-up period, no redemption or conversion transactions are allowed [15][10]. Fund Offering Details - The fund will be available for subscription from January 9, 2026, to April 8, 2026 [27][6]. - The minimum total subscription amount for the fund is set at 200 million shares, with a total fundraising target of at least 200 million RMB [21][6]. Subscription Requirements - Individual investors can subscribe with a minimum initial amount of 1 RMB through other sales institutions, while the minimum for direct sales is 10,000 RMB [5][18]. - There is no upper limit on the total subscription amount for a single investor, except as specified in the fund's prospectus [5][18]. Investment Strategy - The fund aims to invest primarily in other publicly offered securities investment funds, with at least 80% of its assets allocated to such funds [20]. - The fund may also invest in various financial instruments, including stocks, bonds, and publicly offered infrastructure securities investment funds (REITs) [19][20]. Risk Management - The fund is classified as a mixed fund of funds, which implies a risk and expected return profile higher than bond funds but lower than equity funds [10][11]. - The fund may invest in Hong Kong stocks, which introduces specific risks related to market volatility and currency fluctuations [11][12]. Fund Management - The fund is managed by China Europe Fund Management Co., Ltd., with the custodian being China Merchants Bank Co., Ltd. [1][54]. - The fund's management is committed to prudent and diligent asset management, although it does not guarantee profits or protect against losses [12][54].

Core Viewpoint - The public fund market in China has kicked off the new year with the launch of 44 new funds, primarily focusing on equity products, indicating strong confidence in future market trends [2][4]. Fund Issuance Overview - A total of 44 new public funds were launched during the week of January 5 to January 9, 2026, with equity products being the main focus [4][8]. - Among the new funds, 19 were actively managed equity funds and 12 were index funds, with 16 of the actively managed funds being mixed equity funds [4][10]. Thematic Focus of New Funds - Many new funds are designed to fill gaps in existing product lines or to align with future market trends, such as themes related to dividends, overseas investments, technology, and consumption [2][5]. - Specific funds like Huatai-PineBridge Technology Leading focus on global competitiveness in Chinese technology, targeting areas such as AI innovation and semiconductor equipment [4][5]. Management and Strategy Insights - Experienced fund managers are at the helm of several new funds, such as Yang Dong's Guangfa Research Selection, which combines subjective research with quantitative models [5][10]. - The investment strategies of new funds include a focus on high-quality cyclical assets and sectors like internet, consumption, telecommunications, and traditional manufacturing [4][5]. Market Trends and Future Outlook - The public fund issuance in 2025 was significant, with 1,549 funds launched and a total fundraising of 1,204.139 billion yuan, marking the second-highest issuance year in history [9][10]. - The outlook for 2026 suggests a continuation of the trend with a balanced focus on equity and fixed income products, driven by the recovery of bond allocation value and the entry of long-term funds [10].

Fund Overview - The fund is named "Zhongou Yingxiang Stable 6-Month Holding Period Mixed Fund of Funds (FOF)" and has been approved for registration by the China Securities Regulatory Commission (CSRC) [1] - The fund is managed by Zhongou Fund Management Co., Ltd., with CITIC Bank as the custodian [1][2] - It operates as a contract-based open-end fund with a lock-up period of 6 months for each fund share, after which it enters an open holding period [1][2] Fund Issuance Details - The fund will be publicly offered from January 26, 2026, to February 4, 2026 [5][27] - The minimum total subscription amount for the fund is 200 million shares, equivalent to at least 200 million RMB [9][21] - The fund is available for individual investors, institutional investors, qualified foreign investors, and other investors permitted by laws and regulations [7][18] Subscription and Redemption - The minimum initial subscription amount for other sales institutions is 1 RMB, while for direct sales, it is 10,000 RMB [8][23] - Each fund share has a lock-up period of 6 months, during which no redemption or transfer is allowed [10][15] - After the lock-up period, shares can be redeemed or transferred starting from the next business day [10][16] Investment Strategy - The fund aims for long-term stable appreciation of assets by flexibly investing in various funds and other assets while strictly controlling portfolio risks [16] - It primarily invests over 80% of its assets in other publicly offered funds approved by the CSRC, with a maximum of 20% in QDII and Hong Kong mutual funds [19][20] Fund Management and Fees - The fund management company may adjust the subscription limits based on market conditions and will announce any changes [24][30] - The A-class shares will incur subscription fees, while C-class shares will not [30][31] - The fund's expenses related to legal disclosures, accounting, and other fees will be borne by the fund management company and not from the fund's assets [57]

Group 1 - The core viewpoint of the news is that 海思科 (Haisco) has shown a slight increase in stock price, reaching 51.14 yuan per share, with a total market capitalization of 57.273 billion yuan as of December 31 [1] - 海思科's main business involves the research, development, production, and sales of chemical pharmaceuticals, with revenue composition as follows: anesthetic products 39.81%, cooperative product-related income 23.59%, other indications 17.02%, parenteral nutrition 10.32%, antiemetics for tumors 8.15%, and other (supplementary) 0.86% [1] Group 2 - 中欧医疗健康混合A (China Europe Medical Health Mixed A) fund has increased its holdings in 海思科 by 121,200 shares, bringing its total to 21,397,500 shares, which accounts for 4.44% of the circulating shares [2] - The fund has achieved a year-to-date return of 13.6% and a one-year return of 11.58%, ranking 5,297 out of 8,085 in its category [2] Group 3 - The fund manager of 中欧医疗健康混合A is 葛兰 (Gelan) and 赵磊 (Zhao Lei), with total fund assets of 435.44 billion yuan and 329.54 billion yuan respectively [3] - 葛兰 has a tenure of 10 years and 340 days, with the best fund return of 97.86% and the worst return of -35.13% during her tenure [3] Group 4 - 中欧医疗健康混合A has 海思科 as its tenth largest holding, representing 3.47% of the fund's net value, with a floating profit of approximately 11.1267 million yuan [4]

2025 年 12 月 30 日 中欧基金吉翔：专注发掘具有长期 竞争优势个股的价值型基金经理 ——基金经理研究系列报告之九十 相关研究 证券分析师 白皓天 A0230525070001 baiht@swsresearch.com 蒋辛 A0230521080002 jiangxin@swsresearch.com 邓虎 A0230520070003 denghu@swsresearch.com 联系人 白皓天 A0230525070001 baiht@swsresearch.com 权 益 量 化 研 究 证 券 研 究 报 告 请务必仔细阅读正文之后的各项信息披露与声明 本研究报告仅通过邮件提供给 博时基金 博时基金管理有限公司(researchreport@bosera.com) 使用。1 其 他 权 益 类 产 品 - ⚫ 价值风格的配置价值：长期投资性价比更高，日历效应提示当下配置价值：价值是一类 持有体验度较好的风格策略：（1）从长期配置维度下相对占优；（2）大多数时间下夏 普比明显更高；（3）最大回撤明显更低、创新高能力更强。日历效应反映近期价值风格 的配置价值：观察近 10 年时间中价值风格在 ...

公告送出日期：2025年12月29日 1.公告基本信息 ■ 2.日常申购、赎回、转换业务的办理时间 根据中欧同益一年定期开放债券型发起式证券投资基金（以下简称"本基金"）《基金合同》、《招募说 明书》的规定，本基金每年开放一次，每个开放期原则上不低于5个工作日不超过20个工作日。每个开 放期的首日为基金合同生效日的每年年度对日。 本基金的首个封闭期为自基金合同生效日起至第一个开放期的首日（不含该日）之间的期间，之后的封 闭期为每相邻两个开放期之间的期间。本基金在封闭期内不办理申购与赎回业务，也不上市交易。 开放期的具体时间以基金管理人届时公告为准，且基金管理人最迟应于开放期开始前2日进行公告。如 在开放期内发生不可抗力或其他情形致使基金无法按时开放申购与赎回业务的，开放期时间中止计算， 在不可抗力或其他情形影响因素消除之日次一工作日起，继续计算该开放期时间，直到满足开放期的时 间要求。 根据上述约定，本基金将于2025年12月31日（含当日）进入开放期，开放时间为2025年12月31日（含） 至2026年1月15日（含），在此期间接受投资者的申购、赎回、转换业务申请。 3.日常申购业务 其他销售机构的销售网点 ...

公告送出日期：2025年12月26日 1.公告基本信息 ■ 2.其他需要提示的事项 为更好地保证中欧预见平衡养老目标三年持有期混合型发起式基金中基金（FOF）（以下简称"本基 金"）的稳定运作，保护基金份额持有人利益，根据法律法规、本基金基金合同、招募说明书的相关规 定，中欧基金管理有限公司决定自2025年12月26日（含）起，暂停本基金的申购、转换转入、定期定额 投资业务。 本基金暂停办理相关业务期间，其他业务仍照常办理。 若有疑问，投资者可通过登录中欧基金管理有限公司网站（www.zofund.com），或拨打客户服务电话 400-700-9700、021-68609700咨询相关信息。 特此公告。 中欧基金管理有限公司 2025年12月26日 中欧安财定期开放债券型发起式 证券投资基金调整开放期的公告 根据2025年12月17日发布的《中欧安财定期开放债券型发起式证券投资基金开放申购、赎回、转换业务 的公告》，中欧安财定期开放债券型发起式证券投资基金（以下简称"本基金"）原定开放期为2025年12 月22日至2025年12月26日。 根据《中欧安财定期开放债券型发起式证券投资基金基金合同》（以下简称"《 ...